Associations of Antenatal Corticosteroids With Neurodevelopment in Children Aged 27-30 Months: A Population-Based Cohort Study
- PMID: 39971868
- PMCID: PMC12051224
- DOI: 10.1111/1471-0528.18101
Associations of Antenatal Corticosteroids With Neurodevelopment in Children Aged 27-30 Months: A Population-Based Cohort Study
Abstract
Objective: To examine the associations of antenatal corticosteroid (ACS) exposure with neurodevelopment in early childhood, and how these vary with gestational age at birth.
Design: Population-based cohort study.
Setting: Scotland, UK.
Population: 285 637 singleton children born at 28-41 weeks' gestation, between 1st January 2011 and 31st December 2017, who underwent health reviews at 27-30 months of age.
Methods: Logistic and linear regression analyses, stratified by gestation at birth (28-33, 34-36, 37-38 and 39-41 weeks' gestation), were used to evaluate the associations between ACS exposure and neurodevelopmental outcomes, and adjusted for maternal age, body mass index, diabetes, antenatal smoking, parity, neighbourhood deprivation, birth year, child sex and age at review.
Main outcome measures: Practitioner-identified concerns about any neurodevelopmental domain, and the average of five domain scores on neurodevelopmental milestones from the parent-rated Ages and Stages Questionnaire (ASQ-3).
Results: After adjustment for covariates, ACS exposure was associated with reduced neurodevelopmental concerns in children born at 28-33 weeks' gestation (OR = 0.79, 95% CI = 0.62-0.999) and with increased neurodevelopmental concerns in children born at 34-36 weeks' gestation (OR = 1.11, 95% CI = 1.01-1.21). No independent associations emerged in children born at later gestations. ACS exposure was not associated with ASQ-3 scores in any gestational age group.
Conclusions: In early childhood, ACS exposure was associated with statistically significantly reduced neurodevelopmental concerns in children born at 28-33 weeks' gestation, and with statistically significantly increased neurodevelopment concerns in children born at 34-36 weeks' gestation. However, the effect sizes of these associations were small. No independent associations were found between ACS exposure and neurodevelopment in term-born children.
Keywords: antenatal corticosteroids; neurodevelopment; preterm birth.
© 2025 The Author(s). BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Conflict of interest statement
The Co‐OPT ACS study is funded through a Wellcome Trust Clinical Career Development Fellowship grant (Funding Reference number 209560/Z/17) awarded to SJS. ML‐P is supported by grants from the Academy of Finland (330206). FD is supported by the Swiss National Science Foundation (P500PM_206634) and the Bangeter‐Rhyner Foundation. HZ is supported by a UNSW Scientia Program Award. DB is supported by a National Health and Medical Research Council Investigator Grant (GTN1175744). Research at Murdoch Children's Research Institute (DB, JEM) is supported by the Victorian Government's Operational Infrastructure Program. KD is funded by Health Education England (HEE)/NIHR. CG‐B is supported by research grants from NHLBI, NICHD and NIHMD, and has received research funding from HealthCore Inc/SERA Prognostics Inc. and MIRVIE Inc. LHP is supported by a Borregaard Clinical Ascending Investigator Grant from the Novo Nordisk Foundation (NNF18OC0054457). JPV is supported by an Australian National Health and Medical Research Council (NHMRC) Investigator grant (GNT1194248). EMcG acknowledges support of the NIHR North West Coast Scholars' Programme. RMR acknowledges the support of the British Heart Foundation (RE/18/5/34216). The remaining authors declare no conflicts of interest.
Figures

Similar articles
-
Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.JAMA. 2011 Dec 7;306(21):2348-58. doi: 10.1001/jama.2011.1752. JAMA. 2011. PMID: 22147379 Free PMC article.
-
Timing of antenatal corticosteroid exposure and its association with childhood mental disorders in early- and full-term births: A population-based cohort study.Eur J Pediatr. 2025 Feb 6;184(2):181. doi: 10.1007/s00431-025-05994-0. Eur J Pediatr. 2025. PMID: 39912937
-
Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.Am J Obstet Gynecol. 2021 Sep;225(3):276.e1-276.e9. doi: 10.1016/j.ajog.2021.03.027. Epub 2021 Mar 30. Am J Obstet Gynecol. 2021. PMID: 33798481
-
Long-Term Outcomes of Multiple versus a Single Course of Antenatal Steroids: A Systematic Review.Am J Perinatol. 2024 Mar;41(4):395-404. doi: 10.1055/s-0042-1760386. Epub 2023 Feb 1. Am J Perinatol. 2024. PMID: 36724821
-
The proportions of term or late preterm births after exposure to early antenatal corticosteroids, and outcomes: systematic review and meta-analysis of 1.6 million infants.BMJ. 2023 Aug 2;382:e076035. doi: 10.1136/bmj-2023-076035. BMJ. 2023. PMID: 37532269 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical